Cancer Diagnostics Market set to exceed USD 156 billion by 2024

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe.

Delaware, Selbyville - June 13, 2019 /MarketersMedia/ —

Cancer Diagnostics Market is set to exceed USD 156 billion by 2024; according to a new research report.
Increasing prevalence of cancer across the globe will be major driving factor for cancer diagnostics market. World Health Organization reported that cancer accounted for 8.8 million deaths in 2015 and was second leading cause of mortality. Unhealthy eating habits and changing lifestyle are further expected to boost prevalence in near future rendering significant positive impact on demand for better cancer diagnostic methods.

Increasing government initiatives to spread awareness pertaining to benefits of early diagnosis will boost cancer diagnostics market growth over the forecast timeframe. Awareness and accessibility of cancer diagnostic products is lower in developing and underdeveloped regions. Private as well as government organizations are conducting awareness campaigns to educate people regarding the importance of early diagnosis. Such activities will influence industrial growth. For instance, Roche in partnership with China Cancer Rehabilitation Society (CCRS) conducted ‘Run for Her' campaign to raise awareness about mammography.

Request a sample of this premium report titled at https://www.marketstudyreport.com/request-a-sample/859978/?utm_source=MM-VHS

Recent technological advancements enabling quick and accurate diagnosis will propel cancer diagnostics market growth. Patients are receiving treatment specifically tailored with accordance to their genetic makeup with the help of diagnosis based of next generation sequencing and liquid biopsy. Advent of such technologies in near future will support industry growth.

However, prohibitive cost of diagnosis is hampering adoption rates in countries with low income levels. Risk of radiations exposure will further impede market growth over the forecast period.

Imaging application segment held largest revenue share in 2016 and the trend is expected to continue over the forecast timeframe owing to wide range of applicability of imaging devices to detect majority of cancer types. Advent of technologically advanced devices such as computed tomography and positron emission tomography devices will positively impact market growth. These devices provide high quality imaging at lower radiation dose. The side effects associated with usage of some conventional imaging devices due to radiation exposure will hinder segment growth to some extent.

The liver-lung cancer application segment accounted for majority of market share in 2016. The segment growth is largely supported by increasing prevalence due to changing dietary habits such as increasing alcohol consumption and smoking.

U.S. dominated cancer diagnostics market in 2016, due to high research and development activities focused at developing better diagnostic methods. Presence of leading medical technology and biotechnology firms coupled with high adoption rates of technologically superior diagnostic methods will drive the U.S. cancer diagnostics market growth over the forecast timeframe.

China cancer diagnostic market should witness robust growth due to presence of large patient pool and increasing disposable income. Growing awareness pertaining to benefits of early diagnosis will propel market growth. However, being a price sensitive market, inflated cost of some advanced diagnostic tests may limit regional growth to some extent.

Request a discount on standard prices of this premium report titled at https://www.marketstudyreport.com/check-for-discount/859978/?utm_source=MM-VHS

Some of the key industry players operating in global cancer diagnostics market are Sienna Cancer Diagnostics, F. Hoffmann-La Roche, Becton, Dickinson and Company, C.R. Bard, Qiagen, Abbott Laboratories, Hoffmann-La Roche, Thermo Fisher Scientific, Siemens AG, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips, Toshiba Medical Systems Corporation, Agilent Technologies, and Hologic. Industry players are trying to garner higher market share through various organic as well as inorganic growth strategies. The companies in the industry are further trying to develop cost-effective and accurate diagnostics methods to get a competitive edge.

Report Content

Chapter 1. Methodology

1.1. Methodology

1.1.1. Initial data exploration

1.1.2. Statistical model and forecast

1.1.3. Industry insights and validation

1.1.4. Market definition and forecast parameters

1.2. Data sources

1.2.1. Secondary

1.2.2. Primary

Chapter 2. Executive Summary

2.1. Cancer diagnostics industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Application trends

2.1.3. Cancer type trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Cancer Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.2. Industry pitfalls & challenges

3.4. Growth potential analysis

3.4.1. By application

3.4.2. By cancer type

3.4.3. By end-use

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2016

3.7.1. Business overview

3.7.2. Revenue analysis

3.7.3. Product landscape

3.7.4. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Cancer Diagnostics Market, By Application

4.1. Global cancer diagnostics market share, by application, 2016 & 2024

4.2. Tumor biomarkers tests

4.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3. Imaging

4.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.1. Ultrasound and Radiology

4.3.1.1.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.2. Mammography

4.3.1.2.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.3. MRI Scan

4.3.1.3.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.4. PET Scan

4.3.1.4.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.5. CT Scan

4.3.1.5.1. Market estimates and forecast, by region, 2013 - 2024

4.3.1.6. SPECT & Others

4.3.1.6.1. Market estimates and forecast, by region, 2013 - 2024

4.4. Biopsy

4.4.1. Market estimates and forecast, by region, 2013 - 2024

4.5. Liquid Biopsy

4.5.1. Market estimates and forecast, by region, 2013 - 2024

4.6. Immunohistochemistry

4.6.1. Market estimates and forecast, by region, 2013 - 2024

4.7. In Situ Hybridization

4.7.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 5. Cancer Diagnostics Market, By Cancer type

5.1. Global cancer diagnostics market share, by cancer type, 2016 & 2024

5.2. Bladder Cancer

5.2.1. Market estimates and forecast, by region, 2013 - 2024

5.3. Breast Cancer

5.3.1. Market estimates and forecast, by region, 2013 - 2024

5.4. Colon and Rectal Cancer

5.4.1. Market estimates and forecast, by region, 2013 - 2024

5.5. Endometrial Cancer

5.5.1. Market estimates and forecast, by region, 2013 - 2024

5.6. Kidney Cancer

5.6.1. Market estimates and forecast, by region, 2013 - 2024

5.7. Leukemia

5.7.1. Market estimates and forecast, by region, 2013 - 2024

5.8. Liver-Lung Cancer

5.8.1. Market estimates and forecast, by region, 2013 - 2024

5.9. Melanoma

5.9.1. Market estimates and forecast, by region, 2013 - 2024

5.10. Non-Hodgkin Lymphoma

5.10.1. Market estimates and forecast, by region, 2013 - 2024

5.11. Pancreatic Cancer

5.11.1. Market estimates and forecast, by region, 2013 - 2024

5.12. Prostate Cancer

5.12.1. Market estimates and forecast, by region, 2013 - 2024

5.13. Thyroid Cancer

5.13.1. Market estimates and forecast, by region, 2013 - 2024

5.14. Others

5.14.1. Market estimates and forecast, by region, 2013 - 2024

Complete report titled at https://www.marketstudyreport.com/reports/cancer-diagnostics-market

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com/

Source URL: https://marketersmedia.com/cancer-diagnostics-market-set-to-exceed-usd-156-billion-by-2024/523987

Source: MarketersMedia

Release ID: 523987

More News From The Sport Ship

Iranian female soccer fan dies after setting herself on fire

Sep 18, 2019

DUBAI, United Arab Emirates — An Iranian woman detained for dressing as a man to sneak into a soccer stadium to watch a match has died after setting herself on fire upon learning she could spend six months in prison, semi-official news outlets reported Tuesday. The self-immolation death of 29-year-old Sahar Khodayari has shocked Iranian officials and the public, becoming an immediate hashtag trend across social media in the Islamic Republic. It also comes as FIFA is working with Iranian authorities to overcome a ban on women entering stadiums for men's games, a ban in place since the country's 1979...

Abdul Qadir, Pakistan legspinning great, dies at age 63

Sep 18, 2019

LAHORE, Pakistan — Abdul Qadir, the former Pakistan cricketer who was widely regarded as one of the greatest legspinners in history, died of a cardiac arrest on Friday. He was 63. Qadir's son, Salman Qadir, told reporters in Lahore his father was rushed to hospital but did not survive. The Pakistan Cricket Board said on its official Twitter account it was "shocked" and "devastated" by the death of the "maestro." Qadir played 67 tests from 1977-90, taking 236 wickets including 9-56 against England at Lahore in 1987. He made his one-day international debut in the 1983 World Cup, and took...

New Zealand draws series 1-1 with innings win vs. Sri Lanka

Sep 18, 2019

COLOMBO, Sri Lanka — New Zealand beat Sri Lanka by an innings and 65 runs in the second test to level the two-match series 1-1 on Monday. Needing 187 runs in the second innings to make New Zealand bat again, Sri Lanka was bowled out for 122 runs in the final session despite a fighting 51 off 162 deliveries from wicketkeeper Niroshan Dickwella. Sri Lanka won the first test by six wickets in Galle. The match was curtailed by rain for most part but New Zealand played positive cricket to force a result. Sri Lanka started the last session at...

New Zealand set Sri Lanka 268 runs to win 1st test

Sep 18, 2019

GALLE, Sri Lanka — New Zealand set Sri Lanka a challenging 268-run target to win the first cricket test against Sri Lanka on Saturday after its lower order rallied around B.J Watling to salvage the team from a precarious position. The Black Caps were bowled out for 285 in their second innings after struggling on 124 for six. Watling led their resurgence, sharing a 54-run partnership with Tim Southee and adding 46 runs with William Somerville. New Zealand's tail-enders then put on 36 and 25 runs respectively for the ninth and 10th wickets. The target could prove challenging, with the...

Sri Lanka on top as New Zealand slumps to 124-6

Sep 18, 2019

GALLE, Sri Lanka — Spin bowlers Lasith Embuldeniya and Dhananjaya de Silva shared five wickets as Sri Lanka appeared in control of the first test after restricting New Zealand to 124-6 Friday at tea on Day 3. The Back Caps lead Sri Lanka by 106 runs with four second-innings wickets left. New Zealand resumed after lunch on 18-1, having earlier erased a slender 18-run deficit after dismissing Sri Lanka for 267 in its first innings. But the visitors struggled in the second session with spinners extracting more turn and bounce at Galle Stadium. Kiwi captain Kane Williamson, who failed to...

About Us

We’re all about evolving the love of sports. With The Sport Ship, you can up your game and receive all the latest news about the sports world before anyone else.

Contact us: sales[at]thesportship.com

Subscribe Now!